Reports for SANDOZ CANADA INCORPORATED

Company Name

SANDOZ CANADA INCORPORATED

Totals

Shortage reports

1819

Actual shortage: 54 (3%)
Anticipated shortage: 1 (0%)
Avoided shortage: 13 (1%)
Resolved: 1751 (96%)

Discontinuation Reports

74

To be discontinued: 1 (1%)
Discontinued: 71 (96%)
Reversed: 2 (3%)

Late reports

439 (23%)

Overdue reports

3 (5%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ OLMESARTAN 40MG TABLET Resolved 2022-09-27 2022-12-29 170347
SANDOZ OLMESARTAN 40MG TABLET Resolved 2022-12-28 2023-01-19 179583
SANDOZ OLMESARTAN 20MG TABLET Actual shortage 2024-03-25 2024-04-23 223197
SANDOZ OLMESARTAN 20MG TABLET Actual shortage 2024-04-02 2024-04-08 224166
SANDOZ OLOPATADINE 0.1% SOLUTION Resolved 2019-07-16 2019-09-10 89412
SANDOZ OLOPATADINE 0.1% SOLUTION Resolved 2021-04-27 2021-05-03 138115
SANDOZ OLOPATADINE 0.1% SOLUTION Resolved 2021-12-20 2021-12-30 151576
SANDOZ OLOPATADINE 0.2% 0.2% SOLUTION Resolved 2017-09-07 2017-10-25 21353
SANDOZ OLOPATADINE 0.2% 0.2% SOLUTION Resolved 2021-05-17 2021-06-14 139481
SANDOZ OLOPATADINE 0.2% 0.2% SOLUTION Resolved 2022-08-03 2022-08-18 165980
SANDOZ OLOPATADINE 0.2% 0.2% SOLUTION Actual shortage 2024-03-18 2024-04-23 222614
SANDOZ OMEPRAZOLE 20MG CAPSULE (DELAYED RELEASE) Resolved 2017-03-14 2017-05-08 2711
SANDOZ OMEPRAZOLE 20MG CAPSULE (DELAYED RELEASE) Resolved 2017-03-15 2017-05-08 2893
SANDOZ OMEPRAZOLE 10MG CAPSULE (DELAYED RELEASE) Resolved 2018-08-29 2018-10-16 59540
SANDOZ OMEPRAZOLE 10MG CAPSULE (DELAYED RELEASE) Resolved 2021-09-20 2021-12-06 145904
SANDOZ OMEPRAZOLE 20MG CAPSULE (DELAYED RELEASE) Resolved 2022-09-27 2022-11-29 170350
SANDOZ OMEPRAZOLE 10MG CAPSULE (DELAYED RELEASE) Resolved 2023-10-02 2023-10-19 205814
SANDOZ OMEPRAZOLE 20MG CAPSULE (DELAYED RELEASE) Resolved 2024-01-08 2024-04-03 215347
SANDOZ OMEPRAZOLE 20MG CAPSULE (DELAYED RELEASE) Resolved 2024-04-02 2024-04-03 224142
SANDOZ ONDANSETRON 4MG TABLET Resolved 2017-09-07 2017-09-26 21298

Showing 1221 to 1240 of 1819

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265
MICRO PLUS 6 (CONCENTRATE) 75MCG 60MCG 10MCG 0.5MG 1MG 5MG LIQUID Discontinued 2021-10-25 2021-10-26 147927
MILRINONE LACTATE INJECTION 1MG SOLUTION Discontinued 2022-06-17 2022-06-18 163000
OLANZAPINE FOR INJECTION 10MG POWDER FOR SOLUTION Discontinued 2020-06-22 2020-06-22 118553
POLYTOPIC 500UNIT 10000UNIT OINTMENT Discontinued 2020-04-01 2020-04-01 110309

Showing 1 to 20 of 74